CD24 Mouse Monoclonal Antibody [Clone ID: 32D12]
CAT#: AM26050PU-N
CD24 mouse monoclonal antibody, clone 32D12, Aff - Purified
Need it in bulk or conjugated?
Get a free quote
CNY 6150.00
货期*
5周
规格
Specifications
| Product Data | |
| Clone Name | 32D12 |
| Applications | FC, IHC |
| Recommend Dilution | Immunohistochemistry on frozen sections: 1 μg/ml (1:200). Has been described to work in FACS. Suggested positive control: Human tonsil. |
| Reactivity | Human |
| Host | Mouse |
| Clonality | Monoclonal |
| Specificity | This antibody detects CD24. |
| Isotype | IgG1 |
| Formulation | Stock solution contains 0.2mg/ml IgG, phosphate buffered saline pH 7.2 (PBS), 5mg/ml bovine serum albumin (BSA), and 0.09% sodium azide as a preservative. State: Aff - Purified State: Lyophilized Ig fraction |
| Reconstitution Method | Reconstitute by adding 0.5ml distilled water. |
| Purification | Affinity chromatography |
| Conjugation | Unconjugated |
| Storage Condition | Prior to reconstitution store at 2-8°C. Following reconstitution store (in aliquots) at -20°C. Avoid repeated freezing and thawing. |
| Gene Name | CD24 molecule |
| Database Link | |
| Background | CD24 antigen is expressed throughout Bcell development and is downregulated as bone marrow progenitors mature. CD24 expression is lost when human B-cells become plasma cells. The cellular function for human CD24 is unknown so far. Diagnostically, it can serve as a marker for staging B-cell development, and it is expressed at high levels in small cell lung carcinoma. CD24 is a member of a family that also includes Heat Stable Antigen HSA and CD52. It is a glycosylphosphatidylinositol (GPI) anchored glycoprotein. |
| Synonyms | X62 heat stable antigen, HSA |
| Note | Molecular weight of antigen: 35 - 45 kD. Antigen distribution: Isolated cells: granulocytes. Tissue sections: B-cells (germinal centers weak); follicular dendritic cells; variety of epithelial cell types. |
| Reference Data | |
Documents
| Product Manuals |
| FAQs |
| SDS |
Resources
| 抗体相关资料 |
Customer
Reviews
Loading...
